Statin intensity of patients with definite or probable FH, at baseline and at month-6 of follow-upa.

Ferrières, Jean; Banks, Victoria; Pillas, Demetris; Giorgianni, Francesco; Gantzer, Laurene; Lekens, Beranger; Ricci, Lea; Dova-Boivin, Margaux; Chauny, Jean-Vannak; Villa, Guillermo; Désaméricq, Gaelle

doi:10.1371/journal.pone.0255345.s002

pone.0255345.s002.docx (14.95 kB)

Statin intensity of patients with definite or probable FH, at baseline and at month-6 of follow-up^a.

journal contribution

posted on 2021-08-02, 17:25 authored by Jean Ferrières, Victoria Banks, Demetris Pillas, Francesco Giorgianni, Laurene Gantzer, Beranger Lekens, Lea Ricci, Margaux Dova-Boivin, Jean-Vannak Chauny, Guillermo Villa, Gaelle Désaméricq

^aData are presented as n (%). ^bAny statin, excluding statin + ezetimibe fixed combination. FH, Familial hypercholesterolemia.

(DOCX)

History

Usage metrics

Keywords

6- month PCSK French sample cohort study Background statin Health Improvement Network LLT THIN LDL-C goal Untreated Familial Hypercholesterolemia management Results 116 patients DLCN follow-up Dutch Lipid Clinic Network FH patients

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC